11 results for "Lukas Marcelis"
Showing 1–11 · 0.78 seconds · RSS
-
Journal Article
Rare Brain Tumor in Infancy: Intraparenchymal Meningioma with Suspected Meningioangiomatosis in a Nine‑Month‑Old
An exceptionally rare case is described of intraparenchymal WHO grade 2 meningioma with suspected meningioangiomatosis in a nine‑month‑old boy presenting with absence seizures. MRI revealed a heterogeneously enhancing right frontal mass without dural attachment, encasing MCA branches…
-
Journal Article
The Imaging Appearance of 'EWSR1::PATZ1' Gene Fusion Central Nervous System Tumors
Ewing Sarcoma Breakpoint Region 1 and POZ/BTB And AT Hook Containing Zinc Finger 1 (EWSR1::PATZ1) gene fusion central nervous system (CNS) tumors are increasingly recognized as a potential distinct entity, with only limited reported cases. The imaging characteristics of these tumors have not been…
-
Journal Article
Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
Abstract Breast-implant associated (BIA) lymphoma is an infrequent type of cancer occurring in the fluid and fibrous capsule around a textured breast implant. Recently, both the 2022 WHO 5th edition classification of Haematological tumours (WHO HAEM5) and 2022 International Consensus Classification…
-
Journal Article
BET-Independent Murine Leukemia Virus Integration Is Retargeted In Vivo and Selects Distinct Genomic Elements for Lymphomagenesis
ABSTRACT Moloney murine leukemia virus (MLV) infects BALB/c mice and induces T-cell lymphoma in mice. Retroviral integration is mediated by the interaction of the MLV integrase (IN) with members of the bromodomain and extraterminal motif (BET) protein family (BRD2, BRD3, and BRD4). The introduction…
-
Journal Article
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing
In melanoma, the lymphocytic infiltrate is a prognostic parameter classified morphologically into ‘brisk’, ‘non-brisk’ and ‘absent’ entailing a functional association that has never been proved. Recently, it has been shown that lymphocytic populations can be very heterogeneous, and that anti-PD-1…
-
Journal Article
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
Peripheral T cell lymphoma (PTCL) not otherwise specified (NOS) is a subgroup of PTCL, which has no distinctive features and is poorly characterized at the genetic level. Here, the authors identify two fusion transcripts that activate T cell receptor complex signalling and confer therapeutic…
-
Journal Article
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level
Single-cell omics aim at charting the different types and properties of all cells in the human body in health and disease. Over the past years, myriads of cellular phenotypes have been defined by methods that mostly required cells to be dissociated and removed from their original microenvironment…
-
Journal Article Full text
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
Anosmia, the loss of smell, is a common and often the sole symptom of COVID-19. The onset of the sequence of pathobiological events leading to olfactory dysfunction remains obscure. Here, we have developed a postmortem bedside surgical procedure to harvest endoscopically samples of respiratory and…
-
Journal Article
Xq24/IL13RA1 aberrations as key drivers of female bias in primary mediastinal large B‐cell lymphoma
Abstract Female‐biased incidence in primary mediastinal large B‐cell lymphoma (PMBCL) is enigmatic and points to a potential contribution of the X chromosome in this disease. To elucidate the postulated involvement of X‐linked factor(s), we profiled the X chromosome in 48 diagnostic PMBCLs of male…
-
Journal Article
A Multi-Omics Analysis of Metastatic Melanoma Identifies a Germinal Center-Like Tumor Microenvironment in HLA-DR-Positive Tumor Areas
The emergence of immune checkpoint inhibitors has dramatically changed the therapeutic landscape for patients with advanced melanoma. However, relatively low response rates and a high incidence of severe immune-related adverse events have prompted the search for predictive biomarkers. A positive…